Showing results (1381-1390 of 2,951) with videos related to

Sort By:
Pageof 296
Cancer Investigation|January 27, 2023
Efficacy and Safety of Bevacizumab for Treating Glioblastoma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled TrialsXiaohong Xie, Shangyi Bao, Hong Zhao, et al.
Cancer Investigation|February 6, 2023
Challenges Faced by J-1 International Medical Graduates (IMGs) During COVID-19 PandemicFawzi Abu Rous, Ivy Riano
Cancer Investigation|August 16, 2021
In-Silico Analysis of Differentially Expressed Genes and Their Regulating microRNA Involved in Lymph Node Metastasis in Invasive Breast CarcinomaAnupama Modi, Purvi Purohit, Ashita Gadwal, et al.
Cancer Investigation|August 20, 2021
Nivolumab-Related Dry Mouth and Dry Eye: Cross-Sectional StudyOzgen Ahmet Yildirim, Kerem Poyraz, Erkan Erdur, et al.
Cancer Investigation|January 1, 1987
Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatmentG L Wampler, W H Carter, E D Campbell
Cancer Investigation|November 8, 2022
The Prognostic Value of ADAMTS8 and Its Role as a Tumor Suppressor in Breast CancerQia Zhang, Quist Kanyomse, Chenghao Luo, et al.
Cancer Investigation|December 9, 2025
Prognostic Model Based on NAD+ Metabolism-Related Genes Predicts Breast Cancer Outcomes and Guides ImmunotherapyLi Wang, Xi Mao, Jiaqi Ye, et al.
Cancer Investigation|December 3, 2025
Research Progress of Nutrition and Coagulation-Based Markers as Predictors for Digestive System CancersJiayi Huang, Tingting Zeng
Cancer Investigation|December 17, 2025
Expression of Transmembrane Glycoprotein TROP2 in Triple-Negative Breast Cancer and It's Potential as a Molecular Classifier for Targeted TherapyRoshni Saravanan, Vaishnavi Balasubramanian, Srikanth Swamy Swaroop B, et al.
Cancer Investigation|December 5, 2025
The Neutrophil-to-Lymphocyte Ratio May be the Best Serological Biomarker in Predicting Longer Survival in Neoadjuvant Treatment of Triple-Negative Breast CancerGábor Rubovszky, Norbert Mészáros, Zoltán Mátrai, et al.
Pageof 296